Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
Published Online: 2022-10-?
Journal: DrugsLoading...
Authors: Christine Lee•David Yoho•Gary P. Wang•Humberto Aguilar•Joe Marion•Julia Garcia-Diaz•Lindy Bancke•Maha Assi•Paul Feuerstadt•Sahil Khanna•Scott M. Berry•Thomas Louie•Tricia Braun•Whitfield Knapple•Xin Su
